Job Title: Senior Scientist
Location: Framingham MA
Submitted on: 23-Aug-04
|
|
Job Title |
Business Outlook
Survey |
| Senior Scientist |
Overall business outlook is excellent for Genzyme and the industry.
Growth (headcount) of the BioFormulation department will double from
summer of 2003 to Dec. 2004, to keep pace with an executive mandate to
double the number of products in the clinical pipeline. Genzyme
posiitoned to remain competitive where expiring patents are concerned.
Many orphan drugs still in pipeline where there will be little or no
competition. Genzyme heavily invested in evolving technnologies such as
gene therapy. Moral is good with less than 3% employee turnover in
R&D.
|
|